article_snippet.sent: The third and most effective drug - regorafenib - costs the NHS around £1,000 a week to provide and has been removed from the health service's approved list of treatments.
article_snippet.sent: The mother-of-two, who is yet to tell her young children about her condition, says her cannot afford to buy regorafenib privately and has called on NHS England to reverse The mother-of-two, who is yet to tell her young children about her condition decision.
article_snippet.sent: You can buy regorafenib privately but that costs £3,700 a month and I don't have that kind of money. '
article_snippet.sent: The NHS currently spends in the region of £1.3billion on cancer drugs a year, and receives a further £200million annual boost from the Cancer Drugs Fund - which helps to fund treatments for rare forms of the disease.
article_snippet.sent: NHS England then decides what drugs this money goes towards, with a ruling in January removing regorafenib from the fund's list because the treatment's effectiveness did not represent 'sufficient value for retention'.
article_snippet.sent: The report found that, on average, The report cost £4,493 to provide a four-week cycle of regorafenib to a patient, with the average recipient needing the drug for 23 weeks.
highlights_snippet.sent: Drug would cost NHS England £1,000 a week to provide and mother cannot afford to pay for NHS England privately .